A detailed history of Pinnacle Bancorp, Inc. transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Pinnacle Bancorp, Inc. holds 20 shares of BIO stock, worth $6,797. This represents 0.0% of its overall portfolio holdings.

Number of Shares
20
Previous 20 -0.0%
Holding current value
$6,797
Previous $5,000 20.0%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 15, 2024

SELL
$268.26 - $339.48 $5,365 - $6,789
-20 Reduced 50.0%
20 $5,000
Q4 2023

Jan 25, 2024

BUY
$269.37 - $365.04 $808 - $1,095
3 Added 8.11%
40 $12,000
Q2 2023

Jul 13, 2023

BUY
$359.49 - $486.4 $3,235 - $4,377
9 Added 32.14%
37 $14,000
Q1 2023

Apr 14, 2023

BUY
$418.69 - $503.0 $8,373 - $10,060
20 Added 250.0%
28 $13,000
Q4 2022

Jan 24, 2023

BUY
$351.71 - $456.01 $2,813 - $3,648
8 New
8 $3,000

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.37B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Pinnacle Bancorp, Inc. Portfolio

Follow Pinnacle Bancorp, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pinnacle Bancorp, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pinnacle Bancorp, Inc. with notifications on news.